The STEP trials, which enrolled thousands of patients, documented injection site reactions in approximately 35% of participants, making them uncommon but not unheard of
Clinical Evidence: Semaglutide Safety in Patients with Structural GI Conditions Major semaglutide trials, including STEP 1 and STEP 2, excluded patients with active gastrointestinal disorders to maintain study rigor
Step 1: Request the denial letter
Takes 1 minute, no email required, not a medical consultation
Use simple relaxation tools such as progressive muscle relaxation or a short body scan when you lie down
Subcutaneous (SC) or intramuscular (IM) injections at lower doses (tens to low hundreds of milligrams) are emerging as practical alternatives for maintenance therapy and wellness applications [3] [11]